SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 56.51-2.4%Dec 23 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (14634)12/10/2004 2:27:47 PM
From: Biomaven  Read Replies (1) of 52153
 
This week's NEJM has an article discussing the virulence of the 1918 pandemic, suggesting that key (based on a mouse model developed by Kobasa) was an over-enthusiastic immune reaction to the particular form of hemagglutinin.

That suggests that some sort of immune modulation may be key. Perhaps ACE inhibitors or ARBs, but my guess is some sort of more specific cytokine blocker is needed. Steroids are always going to be a double-edged sword.

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News